LEADER 04193oam 2200709I 450 001 9910831885003321 005 20240402074457.0 010 $a1-135-92552-6 010 $a0-203-38551-9 010 $a1-135-92545-3 024 7 $a10.4324/9780203385517 035 $a(CKB)2670000000529451 035 $a(EBL)1644472 035 $a(SSID)ssj0001130665 035 $a(PQKBManifestationID)11625881 035 $a(PQKBTitleCode)TC0001130665 035 $a(PQKBWorkID)11110514 035 $a(PQKB)10001699 035 $a(OCoLC)872649733 035 $a(MiAaPQ)EBC1644472 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/35227 035 $a(EXLCZ)992670000000529451 100 $a20180706d2014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBreast cancer gene research and medical practices $etransnational perspectives in the time of BRCA /$fedited by Sahra Gibbon. [et al.] 205 $a1st ed. 210 $cTaylor & Francis$d2014 210 1$aMilton Park, Abingdon, Oxon :$cRoutledge,$d2014. 215 $a1 online resource (248 p.) 225 1 $aGenetics and Society 300 $aDescription based upon print version of record. 311 $a0-415-82406-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Title; Copyright; Contents; List of contributors; Foreword; Preface; Introduction; SECTION I Practices of population, politics and history in the production of BRCA; 1 The presence of the past: 'Ashkenazi BRCA mutations' and transnational differences in categories of 'race' and 'ethnicity': the German case; 2 Mapping Jewish identities: migratory histories and the transnational re-framing of the 'Ashkenazi BRCA mutations' in the UK and Brazil; 3 Genetics to the people: BRCA as public health and the dissemination of cancer risk knowledge 327 $aMiddleword I: Historicizing biomedicine: toward a history of the present of BRCASECTION II Risk, personhood and subjectivity; 4 Situating breast cancer risk in urban India: gender, temporality and social change; 5 Gender trouble? Queering the medical normativity of BRCA femininities; 6 It takes a particular world to produce and enact BRCA testing: the US had it, Italy had another; Middleword II: Pushing the boundaries; SECTION III Shifting terrains of BRCA knowledge and practices; 7 'Empowerment' and the rendering of biocapital in direct-to-consumer personal genomics 327 $a8 The BRCA patent controversies: an international review of patent disputes9 From BRCA to BRCAness: tales of translational research; 10 Ethical analysis of PGD for BRCA: attending to more than risks and benefits; Afterword: Studying BRCA performativity: re-calibrations by and of the social sciences; Index 330 $aThe discovery of the two inherited susceptibility genes BRCA1 and BRCA2 in the mid-1990s created the possibility of predictive genetic testing and led to the establishment of specific medical programmes for those at high risk of developing breast cancer in the UK, US and Europe. In the intervening fifteen years, the medical institutionalisation of these knowledge-practices and accompanying medical techniques for assessing and managing risk have advanced at a rapid pace across multiple national and transnational arenas, whilst also themselves constituting a highly mobile and shifting terrain 410 0$aGenetics and society (Series) 606 $aBreast$xCancer$xGenetic aspects 606 $aBRCA genes 606 $aTumor markers 610 $aSociety and culture: general 610 $aSocial and cultural anthropology 610 $aSociology 615 0$aBreast$xCancer$xGenetic aspects. 615 0$aBRCA genes. 615 0$aTumor markers. 676 $a616.99/449 676 $a616.99449 700 $aGibbon$b Sahra$4edt$01451457 701 $aGibbon$b Sahra$01451457 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910831885003321 996 $aBreast cancer gene research and medical practices$94129930 997 $aUNINA